|

Financial Stress Could Impact Mesothelioma Quality of Life

Financial stress during mesothelioma treatment

Financial stress during treatment is likely to have an impact on both quality of life and outcomes for pleural mesothelioma patients. 

That finding comes from a recent Johns Hopkins study of patients with newly-diagnosed lung cancer. 

The study found that cancer patients who were under financial strain had decreased quality of life. The report appears in the International Journal of Radiation Oncology. It includes a list of guidelines to help identify patients at risk for “financial toxicity”. 

The Financial Burden of Mesothelioma Treatment

Cancer treatment is rarely inexpensive. Thanks to advances in mesothelioma therapies, patient outcomes are improving. But the costs of these cutting-edge mesothelioma treatments can be even higher than standard therapies. 

John Hopkins researchers wanted to see if there was a link between financial stress during cancer treatment, life quality, and outcomes.

They collected household financial information from 97 newly-diagnosed lung cancer patients. A test called the Comprehensive Score for Financial Toxicity was used to assess patients’ level of financial stress. 

Patients then answered the Functional Assessment of Cancer Therapy-Lung test to determine their quality of life. Researchers looked for correlations between the two scores. 

Measuring the Impact of Financial Stress

The median age of the patients studied was 64. Most (52 percent) were men and 77 percent were white. Almost forty percent of the patients reported they were “just getting by” or “struggling” financially. 

Twenty-two percent of the cancer patients had to make “significant life sacrifices” because of financial stress. Fourteen percent had to use savings or retirement to pay for medical expenses.

There was no link between how much money patients anticipated having to spend in the next six months and either financial stress or quality of life. 

The Message for Pleural Mesothelioma Patients

Financial stress is common for cancer patients and can impact their quality of life. 

Quality of life for mesothelioma patients includes things like the ability to participate in day-to-day activities, live without pain, and enjoy time with loved ones. 

The new study showed patients who were “unable to meet daily expenses” or those who had less than a month of savings in the bank were at highest risk for financial stress. Patients under the most strain had less favorable treatment outcomes. 

Mesothelioma patients who are having trouble paying for their treatment may have options. Mesothelioma is almost always caused by asbestos exposure. If an employer’s negligence led to a worker’s mesothelioma, the worker may be entitled to compensation

Source:

Hazell, SZ, et al, “Financial Toxicity in Lung Cancer: An Assessment of Magnitude, Perception, and Impact on Quality of Life”, September 1, 2019, International Journal of Radiation Oncology, Volume 105, Issue 1, pp. S20, https://www.redjournal.org/article/S0360-3016(19)31253-2/fulltext

Similar Posts

  • |

    Chemical in Wine May Improve Mesothelioma Treatment

    There’s new evidence that a compound found in red wine may help improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma. Last year, a team of Korean researchers released the world’s first study on the mesothelioma-fighting power of resveratrol, a natural phenol derived from the skin of red grapes and found in red wine and grape juice. Now, the same team says resveratrol also appears to enhance the chemosensitivity of malignant mesothelioma cells. Study author Yoon-Jin Lee and colleagues discovered  a synergistic cancer-fighting effect in mesothelioma cells treated with both resveratrol and clofarabine, a prescription drug often used to treat acute lymphoblastic leukemia. Together, resveratrol and clofarabine “induced a strong cytotoxic effect” by influencing levels of the tumor suppressor,…

  • |

    Mesothelioma Symptoms May Benefit from Tuberculosis Drugs

    Pleural effusion is the one of most uncomfortable and life-limiting symptoms of pleural mesothelioma. The buildup of fluid in the pleural space around the lungs, which can happen in late stage mesothelioma as well as several other types of cancer, limits breathing and can be painful. Effusion is often one of the primary reasons that mesothelioma patients in the late stages of the disease have trouble taking a full breath and complain of chest pain and fatigue. While pleural fluid can be drained off through thoracentesis or chemically absorbed through pleurodesis, these treatments are painful, risky, and not always effective. Now, a team of researchers in China say they may have discovered a non-invasive method for dealing with pleural effusion caused…

  • |

    Green Tea, Vitamin C, Chemo Fight Mesothelioma ‘Synergistically’

    Another study has found that the beneficial compounds in green tea may be powerful mesothelioma fighters – especially when combined with other drugs and nutrients. Epigallocatechin gallate (EGCG) is the most abundant polyphenol in green tea and is a potent antioxidant. A number of studies have suggested that it may help the body combat various types of cancer, including mesothelioma. Recently, a group of Italian mesothelioma researchers combined EGCG with Vitamin C and a chemotherapy drug called gemcitabine to create a treatment combination called AND (Active Nutrients/Drug). To test the mixture, they administered AND to various mesothelioma cell lines in the laboratory. The result was a “synergistic cytotoxic mechanism”, meaning the ingredients in AND seemed to increase each other’s cancer-fighting properties…

  • |

    Green Tea Component Fights Mesothelioma

    Another study appears to confirm the idea that a compound found in green tea may be a powerful tool for combatting malignant pleural mesothelioma. Epigallocatechin-3-gallate (EGCG) is a potent antioxidant found in abundance in green (though, not black) tea. It has long been thought to help fight cancer and other diseases by reducing the so-called free radicals produced during oxidative stress. Now, a new study conducted in Japan and published in Cancer Cell International finds that EGCG triggered cell death in five different human mesothelioma cell lines by doing just the opposite. “We found that EGCG induced apoptosis (cell death) in all five mesothelioma cell lines in a dose-dependent manner,” write the authors in a summary of their findings. “We further…

  • |

    Medicinal Plant for Mesothelioma?

    A new study suggests that a plant used for centuries in Indian Ayurvedic medicine may be a powerful weapon in the fight against deadly malignant mesothelioma. The bioactive compound Withaferin A (WA) is isolated from the root of Withania somnifera, a plant in the nightshade family also known as Indian ginseng.  A number of previous scientific studies have found evidence to suggest that WA has anti-inflammatory, immuno-modulatory, anti-angiogenic, and anti-cancer properties. In the latest study, published online in the open-access peer-reviewed journal PLos One, researchers at the Karmanos Cancer Institute in Detroit tested the compound in live mice (in vivo) as well as in mesothelioma cells taken from human patients (in vitro). Their objective was to determine whether WA would have…

  • |

    Mesothelioma Patients May Be Low in Antioxidants

    New research suggests that the antioxidant vitamins found in abundance in fruits and vegetable may have a protective effect against malignant pleural mesothelioma. The news comes from a University in Turkey, where environmentally-induced mesothelioma is alarmingly common due to high erionite content in some small towns. Erionite is a naturally-occurring mineral that is structurally similar to asbestos, the primary cause of mesothelioma around the world. Erionite not only exists in the soil in these Turkish towns, but is also incorporated into hundreds of homes built from erionite-laden rocks. In an effort to evaluate whether or not certain key antioxidant vitamins might protect people against the deadly cancer, Turkish researchers enrolled 160 subjects, 42 of whom had been diagnosed with malignant pleural…